✦ LIBER ✦

First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer

✍ Scribed by Saif, Muhammad Wasif; Li, Jia; Lamb, Lynne; Kaley, Kristin; Elligers, Kyle; Jiang, Zaoli; Bussom, Scott; Liu, Shwu-Huey; Cheng, Yung-Chi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of the botanical formulati

✍ M. Wasif Saif; F. Lansigan; S. Ruta; L. Lamb; M. Mezes; K. Elligers; N. Grant; Z 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Phase 2 trial of oxaliplatin plus capeci

✍ Henry Q. Xiong; Gauri R. Varadhachary; Joan C. Blais; Kenneth R. Hess; James L. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

Phase II trial of capecitabine combined

✍ Shi, Sheng-bin; Wang, Meng; Niu, Zuo-xing; Tang, Xiao-yong; Liu, Quan-yun 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 209 KB

Phase II trial of capecitabine plus cisp

✍ Daniel T. T. Chua; Harry Ho-Yin Yiu; Kasan Seetalarom; Alice Wan-Ying Ng; Johan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Phase II study of flutamide as second li

✍ Jivesh J. Sharma; Betty Razvillas; C.D. Stephens; Susan G. Hilsenbeck; Ashu Shar 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 37 KB

Phase II trial with navelbine (NVB) in a

✍ Lluch, A.; Cervantes, A.; Cervera, V.; Casado, A.; García-Conde, J.; Martín, M.; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 140 KB